Literature DB >> 6696672

Posttraumatic venous obstructive retinopathy associated with enlarged optic nerve sheath.

S L Hupp, E G Buckley, S F Byrne, R R Tenzel, J S Glaser, N S Schatz.   

Abstract

A case of posttraumatic unilateral enlargement of the optic nerve sheath associated with a venous obstructive retinopathy and progressive visual loss responded with marked improvement in visual function after nerve sheath decompression. Indirect (closed-head) trauma may be related to the progressive nerve sheath enlargement, venous obstructive retinopathy, and progressive visual loss. It is apparent that a venous stasis retinopathy can result from a posttraumatic optic nerve sheath lesion. Prompt recognition by echographic and/or roentgenographic investigation and subsequent decompression may be curative.

Entities:  

Mesh:

Year:  1984        PMID: 6696672     DOI: 10.1001/archopht.1984.01040030204027

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

1.  Standardized echography of the eye and orbit.

Authors:  S F Byrne
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

2.  Management of traumatic optic neuropathy--a study of 23 patients.

Authors:  J A Mauriello; J DeLuca; A Krieger; M Schulder; L Frohman
Journal:  Br J Ophthalmol       Date:  1992-06       Impact factor: 4.638

3.  Central retinal vein occlusion in young people.

Authors:  G Giuffrè; G Randazzo-Papa; C Palumbo
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

4.  Incidental optic nerve sheath arachnoid cyst: A rare case finding with literature review.

Authors:  Firdaous Touarsa; Ibtissam El Ouali; Najwa Elkettani; Meriem Fikri; Mohamed Jiddane
Journal:  SAGE Open Med Case Rep       Date:  2022-07-22

5.  Optic nerve sheath decompression for visual loss in intracranial hypertension: report from a tertiary care center in South India.

Authors:  Suneetha Nithyanandam; George J Manayath; Ravindra R Battu
Journal:  Indian J Ophthalmol       Date:  2008 Mar-Apr       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.